Chen, X., Heller, M., Nientiedt, C., Falkenstein, M., Herpel, E., Jenzer, M., . . . Debus, J. (2018). Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapy. Urologic oncology, 36(4), . https://doi.org/10.1016/j.urolonc.2017.11.001
Chicago-Zitierstil (17. Ausg.)Chen, Xin, et al. "Overexpression of Nuclear AR-V7 Protein in Primary Prostate Cancer Is an Independent Negative Prognostic Marker in Men with High-risk Disease Receiving Adjuvant Therapy." Urologic Oncology 36, no. 4 (2018). https://doi.org/10.1016/j.urolonc.2017.11.001.
MLA-Zitierstil (9. Ausg.)Chen, Xin, et al. "Overexpression of Nuclear AR-V7 Protein in Primary Prostate Cancer Is an Independent Negative Prognostic Marker in Men with High-risk Disease Receiving Adjuvant Therapy." Urologic Oncology, vol. 36, no. 4, 2018, https://doi.org/10.1016/j.urolonc.2017.11.001.